254 related articles for article (PubMed ID: 21297655)
1. PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making.
Venderbos LD; Roobol MJ
Asian J Androl; 2011 Mar; 13(2):219-24. PubMed ID: 21297655
[TBL] [Abstract][Full Text] [Related]
2. Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.
Wheeler DC; Szymanski KM; Black A; Nelson DE
BMC Cancer; 2011 Apr; 11():148. PubMed ID: 21510865
[TBL] [Abstract][Full Text] [Related]
3. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
[TBL] [Abstract][Full Text] [Related]
4. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
[TBL] [Abstract][Full Text] [Related]
5. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
Etzioni R; Penson DF; Legler JM; di Tommaso D; Boer R; Gann PH; Feuer EJ
J Natl Cancer Inst; 2002 Jul; 94(13):981-90. PubMed ID: 12096083
[TBL] [Abstract][Full Text] [Related]
6. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
[TBL] [Abstract][Full Text] [Related]
7. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
8. How Much Information Do Icelandic Men Receive on Pros and Cons of Prostate-Specific Antigen Testing Prior to Undergoing Testing?
Eiriksdottir VK; Baldursdottir B; Fridriksson JO; Valdimarsdottir HB
Am J Mens Health; 2022; 16(3):15579883221097805. PubMed ID: 35608380
[TBL] [Abstract][Full Text] [Related]
9. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
Gandaglia G; Albers P; Abrahamsson PA; Briganti A; Catto JWF; Chapple CR; Montorsi F; Mottet N; Roobol MJ; Sønksen J; Wirth M; van Poppel H
Eur Urol; 2019 Aug; 76(2):142-150. PubMed ID: 31092338
[TBL] [Abstract][Full Text] [Related]
10. Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam.
Landrey AR; Matlock DD; Andrews L; Bronsert M; Denberg T
J Prim Care Community Health; 2013 Jan; 4(1):67-74. PubMed ID: 23799692
[TBL] [Abstract][Full Text] [Related]
11. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
12. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
13. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
[TBL] [Abstract][Full Text] [Related]
14. Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: a study from the National Prostate Cancer Register (NPCR) of Sweden.
Fridriksson J; Gunseus K; Stattin P
Scand J Urol Nephrol; 2012 Oct; 46(5):326-31. PubMed ID: 22647143
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
Hayat Roshanai A; Nordin K; Berglund G
Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
[TBL] [Abstract][Full Text] [Related]
16. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
Wilt TJ
Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Screening.
Catalona WJ
Med Clin North Am; 2018 Mar; 102(2):199-214. PubMed ID: 29406053
[TBL] [Abstract][Full Text] [Related]
18. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
[TBL] [Abstract][Full Text] [Related]
19. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.
Chan EC; McFall SL; Byrd TL; Mullen PD; Volk RJ; Ureda J; Calderon-Mora J; Morales P; Valdes A; Kay Bartholomew L
Patient Educ Couns; 2011 Aug; 84(2):e44-51. PubMed ID: 21237611
[TBL] [Abstract][Full Text] [Related]
20. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
Malli G
Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]